Related Experiment Video
Updated: Jul 12, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Liver transplantation during the COVID-19 epidemic : recommendations from the Belgian Liver Intestine Transplant
G Dahlqvist1, O Ciccarelli1, H Van Vlierberghe2
1UCL Liver Transplant Program; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Insights
The COVID-19 pandemic created challenges for liver transplantation (LTx) in Belgium, impacting organ donation and patient safety. Recommendations were made to mitigate these effects and ensure safe LTx practices during the health crisis.
Area of Science:
- Medicine
- Hepatology
- Transplantation
Background:
- The COVID-19 pandemic, starting in January 2020, significantly disrupted global health systems.
- Belgium faced the COVID-19 epidemic in March 2020, leading to widespread uncertainty.
- Healthcare professionals demonstrated remarkable adaptability in reconverting facilities for COVID-19 patient care.
Purpose of the Study:
- To address concerns regarding organ donation and liver transplantation (LTx) during the COVID-19 pandemic in Belgium.
- To evaluate the ethical considerations of utilizing limited healthcare resources for LTx amidst the epidemic.
- To propose recommendations for safe and effective LTx practices during the COVID-19 crisis.
Main Methods:
- Review of the impact of the COVID-19 pandemic on liver transplantation protocols.
- Analysis of ethical dilemmas concerning resource allocation in LTx.
- Formulation of recommendations by BeLIAC based on available resources and safety considerations.
Main Results:
- Concerns identified include organ donation shortages, safety of LTx procedures, ethical resource use, and infection risks.
- Potential for de novo COVID-19 infection in patients awaiting or undergoing LTx.
- Development of recommendations to minimize the adverse effects of the pandemic on donation and LTx.
Conclusions:
- The COVID-19 pandemic poses significant challenges to liver transplantation programs.
- Careful consideration of organ donation, patient selection, and safety protocols is crucial.
- Recommendations aim to optimize patient and healthcare professional safety while maintaining LTx services.
Abstract:
Since January 2020, the Novel Coronavirus Disease 2019 (COVID-19) pandemic has dramatically impacted the world. In March 2020, the COVID-19 epidemic reached Belgium creating uncertainty towards all aspects of life. There has been an impressive capacity and solidarity of all healthcare professionals to acutely reconvert facilities to treat these patients. In the context of liver transplantation (LTx), concerns are raised about organ donation shortage and safety, the ethics of using limited healthcare resources for LTx, selection criteria for LTx during the epidemic and the risk of de novo COVID-19 infection on the waiting list and after LTx. BeLIAC makes several recommendations to try to mitigate the deleterious effect that this epidemic has/will have on donation and LTx, taking into account the available resources, and trying to maximize patients and healthcare professionals' safety.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management